— John CarreyrouIt was all beginning to make sense: Holmes and her company had overpromised and then cut corners when they couldn’t deliver. It was one thing to do that with software or a smartphone app, but doing it with a medical product that people relied on to make important health decisions was unconscionable. Toward the end of this second phone conversation,
Replicated under Fair Use from Bad Blood: Secrets and Lies in a Silicon Valley Startup by John Carreyrou.